Chembio Diagnostics Reports Third Quarter 2022 Financial Res

Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today

Related Keywords

United States , Malaysia , United Kingdom , Brazil , Richard Eberly , Philip Taylor , Company Nasdaq , Reszon Diagnostics International , Global Competitiveness Program , Antigen Panel , Exchange Commission , Chembio Diagnostics Inc , Gilmartin Group , Dual Path Platform , Syphilis Treponemal Nontreponemal , Sure Check , Chembio Malaysia , Chief Executive , Investor Relations , Global Competitiveness , Private Securities Litigation Reform Act , Detect Self Test , Annual Report , Quarterly Reports , Chembio , Diagnostics , Reports , Third , Quarter , 2022 , Financial , Results ,